Sundry Photography/iStock Editorial via Getty Images
Johnson & Johnson (NYSE:JNJ) has put its stroke care business up for sale, aiming for a valuation of more than $1B, the Financial Timesreported on Tuesday, citing people familiar with the matter.
Putting up Cerenovus, which manufactures surgical equipment used
